CS logo
small CS logo
Cahaba Research Inc.

Birmingham, Alabama, United States
Research institute in Birmingham, Alabama
4600 Old Hwy 280, Birmingham, AL 35242

About Cahaba Research Inc.


"Clinical Research"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
7
Eli Lilly and Company
3
Janssen Research & Development, LLC
2
Kowa Research Institute, Inc.
2
Appili Therapeutics Inc.
1
Bausch Health Americas, Inc.
1
Boehringer Ingelheim
1
Centrexion Therapeutics
1
Emergo Therapeutics, Inc.
1
Hoffmann-La Roche
1
Ionis Pharmaceuticals, Inc.
1
Total Rows: 16

Clinical Trials at Cahaba Research Inc.


During the past decade, Cahaba Research Inc. conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
2006-07-01
2007-03-01
Completed
The Effect of Betahistine on Body Weight in Obese Subjects
2007-01-01
2007-06-01
Completed
280
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
2012-11-01
2014-10-01
Completed
428
A Phase 3 Study of Tanezumab for Chronic Low Back Pain
2015-08-18
2018-12-20
Completed
1,832
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
2016-08-23
2019-07-15
Completed
154
Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee
2016-01-21
2018-05-14
Completed
698

Rows per page:

1–26 of 26

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Cahaba Research Inc." #1 sponsor was "Pfizer" with 7 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "Appili Therapeutics Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cahaba Research Inc." #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 7Pfizer: 7Eli Lilly and Company: 3Eli Lilly and Company: 3Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Kowa Research Institute, Inc.: 2Kowa Research Institute, Inc.: 2Appili Therapeutics Inc.: 1Appili Therapeutics Inc.: 1Bausch Health Americas, Inc.: 1Bausch Health Americas, Inc.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Centrexion Therapeutics: 1Centrexion Therapeutics: 1Emergo Therapeutics, Inc.: 1Emergo Therapeutics, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3The Cleveland Clinic: 1The Cleveland Clinic: 1

Clinical Trials Conditions at Cahaba Research Inc.


According to Clinical.Site data, the most researched conditions in "Cahaba Research Inc." are "COVID-19" (4 trials), "Obesity" (3 trials), "Hypertension" (2 trials), "Osteoarthritis, Knee" (2 trials) and "Overweight" (2 trials). Many other conditions were trialed in "Cahaba Research Inc." in a lesser frequency.

Clinical Trials Intervention Types at Cahaba Research Inc.


Most popular intervention types in "Cahaba Research Inc." are "Drug" (23 trials), "Other" (5 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Tirzepatide" (3 trials) and "Fenofibrate" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Cahaba Research Inc.


The vast majority of trials in "Cahaba Research Inc." are 26 trials for "All" genders.

Clinical Trials Status at Cahaba Research Inc.


Currently, there are NaN active trials in "Cahaba Research Inc.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Cahaba Research Inc., undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Cahaba Research Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 19Phase 3: 19Phase 2: 6Phase 2: 6Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Active, not recruiting: 3Active, not recruiting: 3Recruiting: 2Recruiting: 2Terminated: 2Terminated: 2